Goldman Sachs Identifies 23 Defensive Stocks for Volatility Protection

Goldman Sachs strategist Ben Snider has identified 23 Russell 1000 stocks in the health care and consumer staples sectors that offer defensive characteristics alongside quality-growth potential. These selections are intended for investors concerned about a deteriorating growth outlook, focusing on companies with low volatility and high free-cash-flow yields. The list includes major names such as Abbott Laboratories, CVS Health, and Merck, aiming to provide stability amidst market uncertainty.
Key points
- Goldman Sachs strategist Ben Snider highlighted 23 Russell 1000 stocks as defensive options with quality-growth traits.
- The recommended stocks are primarily from the Health Care and Consumer Staples sectors, known for lower volatility.
- Key criteria for selection include high free-cash-flow yields and defensive characteristics to protect against downside risk.
- Notable names on the list include Abbott Laboratories (ABT), CVS Health (CVS), Merck (MRK), and The Kroger Co. (KR).
- The recommendations come amid concerns over a deteriorating growth outlook, suggesting a shift toward stability in portfolios.
Background
This move follows recent market volatility where defensive assets like retail giants faced valuation squeezes despite strong operations. Additionally, Goldman Sachs recently shifted to an overweight stance on both stocks and bonds, signaling a broader realignment in portfolio strategies amidst rising yields and inflation uncertainty.
Why it matters
Investors are increasingly seeking stability in the face of potential economic slowdowns. By identifying stocks that combine defensive traits with growth potential, Goldman Sachs provides a strategy to mitigate downside risk while maintaining exposure to quality companies. This approach is particularly relevant as market leaders face scrutiny and volatility rises in sectors like technology and AI.
What to watch
Investors may look to adjust their portfolios to include these defensive stocks, especially if the growth outlook continues to deteriorate. Monitoring the performance of these stocks against broader market indices will be crucial in assessing the effectiveness of this defensive strategy.
- Goldman's defensive stocks with quality-growth characteristics Seeking Alpha
- Goldman Sachs is urging clients to buy 23 stocks from lagging sectors as big tech wobbles Quartz
- Big tech is wobbling. Goldman Sachs says it’s time to buy these 23 unloved stocks instead. MarketWatch
- Goldman Sachs sees S&P 500 earnings at $415 in 2027 but warns narrow leadership is a risk investingLive
- Goldman Sachs sees room for stocks to rise, warns not to chase market leaders Seeking Alpha
Want the full story? Read the original reporting
Read on Seeking Alpha